Innophos Holdings, Inc. (NASDAQ:IPHS) could be one of the worst stocks that investors may not want to consider for their portfolio today as the company shares are trading 3.46% or 1.19 points down from last closing price of $34.44, reaching $33.25 at last check. Any clue why there is so much of action in the IPHS stock? The share price has dropped in 1 of the last 5 days and is up 24.06% over the past week. It will be exciting to see whether the stock manages to continue decreasing or take a minor break for the next few days. The move came on weak volume too with far less shares changing hands than in a normal session. Trading activity as of this writing weakened by -85,270 shares, and in total 112230 shares valued at $3.732 million were seen changing hands compared with 197500 shares valued at $6.802 million recorded at the previous session. You should take into consideration that a falling volume on lower prices shows the bearish trend but this is an early indication which means that the IPHS stock is near its bottom.
Innophos Holdings, Inc. (IPHS) shares have notched a 3-month gain of about 24.06%, but has still advanced 40.4% year to date. By comparison, the stock sank -22.1% over the past 12 months, while it jumped 25.79% over the 1 month. The company’s market cap is around $674.09M, with its short interest ratio standing at 4.19%.
In the current trading session for IPHS, the stock witnessed two major price actions, it rose to a high of $34.7 and was down as much as $33.05 at one point. The high recorded is very low when compared to their 52-week high which is $22.57. The 52-week high is now at -28.38 distance from current price. Their recent low of $46.65 represents a 48.03% recovery. This data is quite important for investors who look to benefit from the recent rise of the company’s stock. The price target currently for IPHS is $43, this is below the recent high that the stock attained. Taking a look at the overall sentimental views of financial analysts, the trading pattern of this stock recently is very clear.
The stock of Innophos Holdings, Inc. earned $1.09 per share in the trailing 12 months and has a P/E ratio of 30.5. You can compare it with that of similar companies in its industry to get a sense of whether the stock you’re looking to purchase is overvalued or undervalued. Its current price to earnings ratio is lower than the ones recorded by the industry which is 32.58 and higher compared to the sector’s average of 23.76. When the P/E ratio is low let’s say below 1.0, then the stock price is considered a good value. IPHS also has P/S multiple of 0.85. This is greater versus the 12 month P/S ratios of other companies in the same indutry. The peer average price to sales ratio is 0.26x.
IPHS‘s last price was up 15.34% as compared to the average trading price of 50 days recorded at $28.83 while enlarging the period to 200 trading days, the average closing price was $28.22. At present, there are 19.57 million in the total number of common shares owned by the public and among those 19.4 million shares have been available to trade. The percentage of shares being held by the company management was 1.6% while institutions stake was 97.3%. The company has generated positive returns on equity over the last 12 months (8.5%). It managed to keep its gross profit margin at 18% over the past 12 months.
When assessing the full upside of the IPHS stock, there is another set of technicals that should be looked into and considered. Its 11.15% gain from moving average of $29.91 has brought about a positive sentiment when calculated over the last 20 days. The market has allocated a beta of 1.45 to the stock. With the beta been greater than one, this implies that the company shares are theoretically more volatile than the market, something that the traders definitely are keeping an eye on.
In the last five years, the EPS of the company has been roughly -8.2%. Though the percentage looks disappointing, extra tailwinds are emerging as looking out over a next 5-year period, with analysts estimating that their earnings will increase annually by 10%. The revenue of the company has retreated at an average annualized rate of about -1 over the last five years. The company recently recorded a drop of -10.5%, but this figure is rather unattractive.
Let’s briefly check the hedge fund interest towards IPHS stock. Hancock Whitney Corp added position in the company after it grew 13.7% or 47,196 shares of its common stock. The hedge fund now owns 53,662 shares worth $1,784,262, SEC documents show. Boston Partners cut assets in the stock as 141624.1 shares have been sold, reducing its stake by -6.1% to 132,985 shares which are currently valued at $4,421,751. In addition, Barrow Hanley Mewhinney & Strauss LLC recently reported that it now owns 36,797 shares making a total of $1,223,500 based on the recent price. This refelects a change of -3.7% in their ownership.